Xuanwen J. Bao
#79 Qingchun Road
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in patients with Advanced Hepatocellular Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 21, 2026
AGPAT3 reshapes tumor cell vulnerability to IFNγ-mediated ferroptosis and enhances immunotherapy efficacy through lipid remodeling.
Journal: Journal for immunotherapy of cancer
Published: February 23, 2026
AGPAT3 reshapes tumor cell vulnerability to IFNγ-mediated ferroptosis and enhances immunotherapy efficacy through lipid remodeling.
Journal: Journal for immunotherapy of cancer
Published: February 23, 2026
Evolution of SPP1+ cavity macrophage-mediated immunotherapy resistance in peritoneal metastasis of colorectal cancer.
Journal: Cell reports. Medicine
Published: December 11, 2025
Nanodelivery of Traditional Chinese Medicine Monomers: An Emerging Strategy to Reprogram the Immunosuppressive Tumor Microenvironment.
Journal: International journal of nanomedicine
Published: October 26, 2025
Oral Streptococcus salivarius Couples Neutrophil IRGM1 Signaling to NET Formation and Colorectal Cancer Metastasis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 27, 2025
High-resolution spatial multi-omics enables prognostic scoring in intrahepatic cholangiocarcinoma.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 29, 2025
Neoadjuvant mFOLFOX6 plus camrelizumab and apatinib in colon cancer and biomarker research via spatiotemporal-omics profiling.
Journal: NPJ precision oncology
Published: July 21, 2025
NKG2D CAR-NK adoptive cellular immunotherapy combined with or without PD-1 blockade in the treatment of patients with metastatic colorectal cancer: an exploratory study.
Journal: Cancer immunology, immunotherapy : CII
Published: July 13, 2025
Immunotherapy in EGFR-mutant NSCLC after TKI resistance: role of mutation subtypes and progression patterns.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 21, 2025
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial.
Journal: Nature cancer
Published: April 19, 2025
Lactylation in cancer: Advances and opportunities for treatment resistance.
Journal: Clinical and translational medicine
Published: March 19, 2025
Last Updated: 09/26/2026